|
|
||||||
|
NIH modifies peer review criteria The Directors of NIH Institutes and Centers adopted updated peer review criteria at a meeting on August 5, 2004. The revisions were developed in conjunction with the NIH Roadmap process to incorporate appropriate emphasis on some important types of biomedical, e.g., interdisciplinary, translational, and clinical projects. These updated review criteria will be effective for research grant applications received on or after January 10, 2005 that fall into the following categories:
Solicited research grant applications submitted in response to Requests for Applications (RFAs) will continue to use the review criteria described in the RFA. Beginning with reviews in the summer of 2005, reviewers will be instructed to use the updated review criteria (shown below) as the basis for evaluating research grant applications and for assigning a single, global score for each scored application. The score should reflect the overall impact that the project could have on the advancement of science. The emphasis on each criterion may vary from one application to another; and an application need not be strong in all categories to be judged likely to have a major scientific impact. Updated NIH Criteria for the Evaluation of All Research Applications 1. Significance. Does this study address an important problem? If the aims of the application are achieved, how will scientific knowledge or clinical practice be advanced? What will be the effect of these studies on the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field? 2. Approach. Are the conceptual or clinical framework, design, methods, and analyses adequately developed, well integrated, well reasoned, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics? 3. Innovation. Is the project original and innovative? For example: Does the project challenge existing paradigms or clinical practice; address an innovative hypothesis or critical barrier to progress in the field? Does the project develop or employ novel concepts, approaches, methodologies, tools, or technologies for this area? 4. Investigators. Are the investigators appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers? Does the investigative team bring complementary and integrated expertise to the project (if applicable)? 5. Environment. Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support? NOTE: Requests for Applications (RFAs), which are published in the NIH Guide to Grants and Contracts, may list additional elements, relating to the specific requirement of the RFA, under each of the above criteria. Additional Review Criteria: In addition to the above criteria,
the following items will continue to be considered in the determination
of scientific merit and the priority score:
|
||||||
|
|
||||||